[HTML][HTML] Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
M Teixeira, P Rodrigues-Santos, P Garrido… - Journal of Pharmacy …, 2012 - journals.lww.com
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.
M Teixeira, P Rodrigues-Santos, P Garrido… - Journal of Pharmacy …, 2012 - europepmc.org
Objective Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
[PDF][PDF] Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
M Teixeira, P Rodrigues-Santos, P Garrido… - Journal of Pharmacy …, 2012 - ciencia.ucp.pt
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
M Teixeira, P Rodrigues-Santos… - … of Pharmacy and …, 2012 - search.proquest.com
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.
M Teixeira, P Rodrigues-Santos, P Garrido… - Journal of Pharmacy …, 2012 - go.gale.com
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
[PDF][PDF] Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
M Teixeira, P Rodrigues-Santos, P Garrido… - Journal of Pharmacy …, 2011 - academia.edu
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
M Teixeira, P Rodrigues-Santos, P Garrido… - Journal of Pharmacy …, 2012 - repositorio.ucp.pt
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
M Teixeira, P Rodrigues-Santos, P Garrido… - Journal of Pharmacy …, 2012 - estudogeral.uc.pt
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.
M Teixeira, P Rodrigues-Santos… - … of Pharmacy & …, 2012 - search.ebscohost.com
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
[HTML][HTML] Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
M Teixeira, P Rodrigues-Santos, P Garrido… - Journal of Pharmacy …, 2012 - ncbi.nlm.nih.gov
Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …
moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a …